GeneDx Holdings Corp.
WGS
$166.95
$1.340.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.72% | 16.40% | |||
| Total Other Revenue | 12.23% | 111.58% | |||
| Total Revenue | 13.68% | 17.88% | |||
| Cost of Revenue | 1.34% | 11.00% | |||
| Gross Profit | 19.22% | 21.25% | |||
| SG&A Expenses | 44.99% | -7.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 28.02% | 2.25% | |||
| Operating Income | -136.28% | 296.88% | |||
| Income Before Tax | -169.94% | 273.68% | |||
| Income Tax Expenses | 200.41% | -155.03% | |||
| Earnings from Continuing Operations | -170.64% | 265.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -170.64% | 265.55% | |||
| EBIT | -136.28% | 296.88% | |||
| EBITDA | -78.73% | 1,244.37% | |||
| EPS Basic | -170.10% | 263.02% | |||
| Normalized Basic EPS | -142.32% | 285.70% | |||
| EPS Diluted | -173.64% | 255.17% | |||
| Normalized Diluted EPS | -144.06% | 278.37% | |||
| Average Basic Shares Outstanding | 0.76% | 1.53% | |||
| Average Diluted Shares Outstanding | -3.21% | 5.71% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||